(Q36449844)

14 August 2017

A population-based study of high-grade gliomas and mutated isocitrate dehydrogenase 1. (English)

1 reference

14 August 2017

3

Jacob Hjelmborg

1 reference

14 August 2017

Rikke H Dahlrot

1

1 reference

14 August 2017

Bjarne W Kristensen

series ordinal

2

1 reference

14 August 2017

Jørn Herrstedt

series ordinal

4

1 reference

14 August 2017

Steinbjørn Hansen

series ordinal

5

1 reference

14 August 2017

20 November 2012

1 reference

International Journal of Clinical and Experimental Pathology

14 August 2017

1 reference

14 August 2017

6

1 reference

14 August 2017

1

1 reference

14 August 2017

31-40

1 reference

Volumetric and MGMT parameters in glioblastoma patients: survival analysis

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Towards personalized therapy for patients with glioblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Prognostic significance of IDH-1 and MGMT in patients with glioblastoma: one step forward, and one step back?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

The presence of stem cell marker-expressing cells is not prognostically significant in glioblastomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Analysis of the IDH1 codon 132 mutation in brain tumors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

The 2007 WHO classification of tumours of the central nervous system

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

The treatment of elderly patients with high-grade gliomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Improving prognosis of glioblastoma in the 21st century: who has benefited most?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Characterization of R132H mutation-specific IDH1 antibody binding in brain tumors

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Parameters assessing neurological status in malignant glioma patients: prognostic value for survival and relapse-free time.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Prognostic factors in elderly patients with supratentorial malignant gliomas.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Radiotherapy for glioblastoma in the elderly.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

What is the appropriate radiotherapy protocol for older patients with newly diagnosed glioblastoma?

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Prognostic factors in malignant gliomas with special reference to intra-arterial chemotherapy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3515987

Survival of high grade glioma patients depends on their age at diagnosis

21 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23236540

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

1 reference

14 August 2017

PubMed publication ID

23236540

1 reference